Deaths Cause Cell Genesys To Stop Cancer Vaccine Trial

August 28, 2008

Cell Genesys Inc. has decided to stop a late-stage trial of their cancer vaccine known as GVAX...Washington (ChattahBox) – Cell Genesys Inc. has decided to stop a late-stage trial of their cancer vaccine known as GVAX.

The company came to the decision to put a stop to the trial after deaths were reported in patients in many patients.

20 more deaths of patients on GVAX took place when compared to patients on placebos.

The company is now going to be investigating the cancer vaccine, to see how this difference in deaths took place.

This new cancer vaccine is said to be very similar to a vaccine from Dendreon called Provenge.

This caused share for the company to hit an all-time low, dropping by 75%.


Comments

Got something to say? **Please Note** - Comments may be edited for clarity or obscenity, and all comments are published at the discretion of ChattahBox.com - Comments are the opinions of the individuals leaving them, and not of ChattahBox.com or its partners. - Please do not spam or submit comments that use copyright materials, hearsay or are based on reports where the supposed fact or quote is not a matter of public knowledge are also not permitted.